Do, Thien Phu
Dømgaard, Mikala
Stefansen, Simon
Steiner, Timothy J.
Ashina, Messoud
Article History
Received: 23 December 2022
Accepted: 15 February 2023
First Online: 24 February 2023
Declarations
:
: Thien Phu Do has received honoraria or personal fees from Teva for lecturing.Mikala Dømgaard reports no conflicts of interest.Simon Stefansen reports no conflicts of interest.Timothy J. Steiner reports no conflicts of interest.Messoud Ashina is a consultant, speaker, or scientific advisor for AbbVie, Allergan, Amgen, Eli Lilly, Lundbeck, Novartis, and Teva and a primary investigator for ongoing AbbVie/Allergan, Amgen, Eli Lilly, Lundbeck, Novartis, and Teva trials. Messoud Ashina has no ownership interest and does not own stocks of any pharmaceutical company. Messoud Ashina serves as associate editor of Cephalalgia, associate editor of the Journal of Headache and Pain, and associate editor of Brain.